Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

# 每周一次司美格鲁肽治疗中国 2 型糖尿病的成本效益优势：长期与短期研究新发现 在当今社会，糖尿病已成为全球范围内的重大公共卫生挑战，严重威胁着人们的健康。特别是 2 型糖尿病，作为糖尿病中最为常见的类型，约占所有糖尿病病例的 90%。在中国，糖尿病患者数量更是高达 1.41 亿，其带来的经济负担也十分沉重，2021 年相关健康支出达 1653 ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

A new study reveals that anti-obesity drugs can help kidney transplant recipients with type 2 diabetes reduce the risk of organ failure and increase survival rates. Researchers found that GLP-1 ...

People taking the drugs had a lower risk of organ failure and death However, the drugs were associated with an increased risk of diabetic retinopathy THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 ...

The control group was treated with Liraglutide, and the observation group was treated with Dulaglutide, both for 24 weeks. The blood glucose levels, biochemical index, insulin resistance index ...

Dulaglutide could significantly decrease risks of both anxiety and depression. Conclusion: Patients with DM receiving GLP1-RA therapy have a greater reduction of the risk of anxiety than that of ...